-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Technical Articles of PharmaNet】With the advancement of medical research, innovative biomedical therapies such as cell therapy and gene therapy have come out one after another, and have become the hotspot of major life science companies, bringing new hope for disease treatment and even cure for patients around the wor.
Although the new generation of therapy has great potential in terms of efficacy, it is especially full of opportunities for diseases that have been difficult to break through in the pa.
But correspondingly, the difficulty and requirements of the manufacturing process are also much higher than the original traditional thera.
So, what are the pitfalls of traditional bioprocessing products in the production of these innovative therapies? How to realize process innovation and provide higher quality guarantee for biopharmaceutical production? Recently, .
Chen Lin, the chief scientist of Biolink, shared with you the current innovative trends of bioprocessing products in these innovative therapies, as well as the innovative ideas and characteristics of the three products launched by Biolink for mRNA and other customers, in a live broadcast for the first ti.
If you want to know the specific content shared by .
Chen Lin, please scan the QR code below to watch the video playback immediate.
Not to be missed!
Although the new generation of therapy has great potential in terms of efficacy, it is especially full of opportunities for diseases that have been difficult to break through in the pa.
But correspondingly, the difficulty and requirements of the manufacturing process are also much higher than the original traditional thera.
So, what are the pitfalls of traditional bioprocessing products in the production of these innovative therapies? How to realize process innovation and provide higher quality guarantee for biopharmaceutical production? Recently, .
Chen Lin, the chief scientist of Biolink, shared with you the current innovative trends of bioprocessing products in these innovative therapies, as well as the innovative ideas and characteristics of the three products launched by Biolink for mRNA and other customers, in a live broadcast for the first ti.
If you want to know the specific content shared by .
Chen Lin, please scan the QR code below to watch the video playback immediate.
Not to be missed!
